Breaks Categories: News

TuesdayAug 10, 2021 12:18 pm

NetworkNewsBreaks – OTC Markets Group Inc. (OTCM) Featured in Earnings Release Research from Sidoti

OTCM Delivers Strong 2Q:21 Results Driven by Market Volatility and Companies Joining Markets OTC Markets Group (OTCQX: OTCM) was featured in a company-sponsored research earnings release note published by Sidoti & Company LLC. The report reads, “Ultimately, we think OTCM’s 2Q:21 results highlight OTCM’s ability to benefit from greater market volatility and an improving backdrop of underlying demand trends and remain confident in OTCM’s ability to drive growth long-term.” To access the full report, visit https://nnw.fm/GiVsp About OTC Markets Group Inc. OTC Markets Group operates the OTCQX(R) Best Market, the OTCQB(R) Venture Market and the Pink(R) Open Market for 11,000…

Continue Reading

TuesdayAug 10, 2021 12:04 pm

NetworkNewsBreaks – Information Services Group Inc. (NASDAQ: III) Featured in Earnings Preview Research from Sidoti

Strong Technology Spending Trends and Initiation of the Dividend Support a Higher Multiple Information Services Group (NASDAQ: III) was featured in a company-sponsored research earnings preview note published by Sidoti & Company LLC. The report reads, “Our 2Q:20 EPS forecast of $0.05 reflects management commentary an improving spending activity by the client base… Our net revenue estimate represents 13.6% year-over-year growth, which we view as consistent with positive industry trends and management commentary.” To access the full report, visit https://nnw.fm/WDxYL About Information Services Group Inc. Information Services Group (“ISG”) is a leading global technology research and advisory firm. A trusted…

Continue Reading

TuesdayAug 10, 2021 11:53 am

NetworkNewsBreaks – STRATTEC SECURITY CORP. (NASDAQ: STRT) Featured in Earnings Release Research from Sidoti

Supply chain disruptions tempered the pace of recovery STRATTEC SECURITY (NASDAQ: STRT) was featured in a company-sponsored research earnings release note published by Sidoti & Company LLC. The report reads, “STRATTEC’s 3Q:F21 results reflect supply-chain disruptions that have tempered the once stalwart recovery in automotive production… At the current pace, we think the company will reinstate the suspended dividend (was $0.56 per share annually) by early F2023 at the latest.” To access the full report, visit https://nnw.fm/ABjff STRT will be presenting at the Sidoti August Virtual Microcap Conference on Thursday, August 19 at 11:30am EDT. As the official media partner,…

Continue Reading

TuesdayAug 10, 2021 11:15 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Marks ‘Major Turning Point’ Through Kasa Wholefoods Division

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that its food and beverage division, Kasa Wholefoods Company S.A.S., has completed its first purchase order, valued at approximately US$1.1 million. The order was for Importaciones y Asesorias Tropi S.A.S. (“Tropi”) as part of the sales agreement announced in July, and Flora expects Kasa to complete similar monthly deliveries moving forward. “We believe this initial sale demonstrates Flora’s ability to rapidly follow through on its commitments and marks a major turning point for our Kasa Wholefoods division. We expect this relationship…

Continue Reading

TuesdayAug 10, 2021 11:05 am

NetworkNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) Releases Update Regarding Mexico Litigation

Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) has provided an update on litigation involving the company’s subsidiary San Pedro Resources SA de CV. The litigation is regarding part of the Evolución property in Zacatecas and was first disclosed in 2019. The company is confirming that, as it reported in July, San Pedro’s appeal to the federal courts of Mexico in respect of the litigation was dismissed, despite the lack of evidence, facts or law to support this outcome. The company has received the formal written decision regarding the appeal; the decision, which is not subject to further legal appeal, appears to uphold the…

Continue Reading

TuesdayAug 10, 2021 10:26 am

NetworkNewsBreaks – Prysm Group’s White Label World Expo Slated for September in Vegas

The Prysm Group has announced that the world’s largest event for professional online sellers and white-label good suppliers is returning this fall. The White Label World Expo is scheduled for Sept. 1–2, 2021, at the Las Vegas Convention Center. The conference will bring together an estimated 15,000 online sellers, suppliers and buyers from across the globe together in one place. This year’s agenda features more than 400 expert speakers and an exhibit hall with more than 600 participants. The speakers will address timely and relevant topics in today’s retail space. According to the announcement, in 2020, more than 2 billion…

Continue Reading

TuesdayAug 10, 2021 10:17 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Partnerships to Explore, Develop Proprietary Psilocybin Formulations

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, has signed agreements with both Calvert Labs and Gad Consulting Services to design, execute and collaborate on exploratory studies related to Tryp's Psilocybin-for-Neuropsychiatric Disorders, or PFN(TM) (“PFN”), program. An Altasciences company, Calvert Labs has established an impressive track record of executing FDA-approved studies across a broad range of therapeutic indications. The two companies will work together to generate toxicology and blood exposure level data related to Tryp's proprietary, psilocybin-based formulation, TRP-8803; the agreement also outlines collaboration to strengthen…

Continue Reading

TuesdayAug 10, 2021 10:12 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation in Q3 Virtual Investor Summit

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), will participate in the upcoming two-day Q3 Virtual Investor Summit. Vivos CEO Kirk Huntsman along with CFO Brad Amman and Ed Loew, Vivos investor relations officer, will be presenting at the event, which will be held Aug. 17–18; their presentation is slated to begin at 9:30 a.m. ET on Aug. 18, 2021. The Vivos presentation will be available online, and a replay of the presentation will be available to view…

Continue Reading

TuesdayAug 10, 2021 10:05 am

NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Deployment of HealthTab(TM) Platform, Patient Testing in Select Shoppers Drug Mart(R) Locations

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that patient testing has begun on the HealthTab(TM) platform in select Shoppers Drug Mart(R) pharmacies. According to the update, participating Shoppers Drug Mart(R) pharmacies have now received their HealthTab(TM) systems and will begin offering screening tests to patients already identified as diabetics or with known conditions associated with pre-diabetes to provide diagnostic support and pharmacist-led consultation services. "We are very excited to pilot point-of-care testing with HealthTab and the Afinion 2 analyzer at select Shoppers Drug Mart(R) pharmacies,” said Frank Hack, director of Complex Care at Shoppers Drug Mart. “We are committed…

Continue Reading

TuesdayAug 10, 2021 9:52 am

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Names Digital Therapy Visionary as Tech Advisor

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has announced that Dr. Ken Weingardt, CEO of Audacious Digital Health, will be serving as senior clinical technology advisor. Weingardt is a clinical psychologist and has served as senior clinical director at Pear Therapeutics. Specifically,  Weingardt will work with MINDCURE's iSTRYM, the company’s digital therapeutics technology (“DTx”) platform, through near-term commercial deployment. iSTRYM is on schedule for MVP deployment in the third quarter of 2021, with commercial deployment slated for first quarter 2022. Weingardt , who most recently served as the director…

Continue Reading